IL-1β, TNF-α, TGF-β, and bFGF expression in bone biopsies before and after parathyroidectomy

Kidney International

Volumn 63, Issue 3, 2003, Pages 899-907

  Lello Santos, Francisco R ^a   Moysés, Rosa M A ^a   Montenegro, Fábio L M ^a   Jorgetti, Vanda ^a   Noronha, Irene L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Growth factors; Renal osteodystrophy

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE BIOPSY; BONE MINERALIZATION; BONE REMODELING; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERPARATHYROIDISM; ILIAC BONE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; UREMIA; BIOPSY; BONE; METABOLISM; MIDDLE AGED; PATHOLOGY; RENAL OSTEODYSTROPHY;

ADOLESCENT; ADULT; BIOPSY; BONE AND BONES; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MALE; MIDDLE AGED; PARATHYROIDECTOMY; RENAL OSTEODYSTROPHY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; UREMIA;

EID: 0037336093     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00835.x     Document Type: Article

References (48)

1. GONZALEZ EA: The role of cytokines in skeletal remodelling: Possible consequences for renal osteodystrophy. Nephrol Dial Transplant 15:945-950, 2000
2. HORY B, DRUEKE TB: The parathyroid-bone axis in uremia: New insights into old questions. Curr Opin Nephrol Hypertens 6:40-48, 1997
3. FERREIRA A, SIMON P, DRÜEKE TB, et al: Potential role of cytokines in renal osteodystrophy. Nephrol Dial Transplant 11:399-400, 1996
4. HERBELIN A, NGUYEN AT, ZINGRAFF J, et al: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int 37:116-125, 1990
5. PEREIRA BJG: Cytokine production in patients on dialysis. Blood Purif 13:135-146, 1995
6. PFEILSCHIFTER J, MUNDY GR, ROODMAN GD; Interleukin 1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118, 1989
7. DEWHIRST FE, AGO JC, PEROS WJ, STASHENKO P: Synergism between parathyroid hormone and interleukin 1 in stimulating bone resorption in organ culture. J Bone Miner Res 2:127-134, 1987
8. 2 production by osteoblastic cells: Role of calcium, calmodulin, and cAMP. Lymphokine Cytokine Res 10:95-99, 1991
9. NGUYEN L, DEWHIRST FE, HAUSCHKA PV, STASHENKO P: Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15-21, 1991
10. GOWEN M, CHAPMAN K, LITTLEWOOD A, et al: Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones. Endocrinology 126:1250-1255, 1990
11. SUDA T, KOBAYASHI K, JIMI E, et al: The molecular basis of osteoclast differentiation and activation. Novartis Found Symp 232:235-247, 2001
12. KOBAYASHI K, TAKAHASHI N, JIMI E, et al: Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of ODF/RANK1-RANK interaction. J Exp Med 191:275-285, 2000
13. Spor MB, ROBERTS AB, WAKEFIELD LM, ASSOIAN RK: Transforming growth factor-β: Biological function and chemical structure. Science 233:532-534, 1986
14. GRESSNER AM, BACHEM MG: Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: Liver fibrosis as a paradigm. Ann Biol Clin (Paris) 52:205-261, 1994
15. NODA M, CAMILLIERE JJ: In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 124:2291-2294, 1989
16. CENTRELLA M, MCCARTHY TL, CANALIS E: Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 262:2869-2874, 1987
17. VARGHESE S, RAMSBY ML, JEFFREY JJ, CANALIS E: Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rats bone cells. Endocrinology 136:2156-2162, 1995
18. NAKAMURA T, HANADA K, TAMURA M, et al: Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136:1276-1284, 1995
19. COBURN JW, SLATOPOLSKY E: Vitamin D, parathyroid hormone, and renal osteodystrophy, in The Kidney, fifth edition, edited by BRENNER BM, RECTOR FC JR, Philadelphia, WB Saunders, 1994, pp1657-1671
20. DE FRANCISCO AM, ELLIS HA, OWEN JP, et al: Parathyroidectomy in chronic renal failure. Quart J Med 218:289-315, 1985
21. ANDRESS D, OTT SM, MALONEY NA, SHERRARD DJ: Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. N Engl J Med 312:468-473, 1985
22. CHARHON SA, BERLAND YF, OLMER MJ, et al: Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients. Kidney Int 27:426-435, 1985
23. MALLUCHE HH, FAUGERE MC: Atlas of Mineralized Bone Histology, Basel, Switzerland, Karger, 1986
24. PARFITT AM, DREZNER MK, GLOURIEUX FH, et al: Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 6:595-610, 1987
25. 3 on the bone in patients with renal osteodystophy. Am J Med 64:101-107, 1978
26. MEUNIER PJ, EDOUARD C, RICHARD D, LAURENT J: Histomorphometry of osteoid tissue. The hyperosteoidoses, in Bone Histomorphometry, edited by MEUNIER P, Paris, Armour-Montagu, 1977, pp 249-262
27. CHARHON SA, CHAVASSIEUX PM, CHAPUY MC, et al: Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. J Lab Clin Med 106:123-131, 1985
28. NORONHA IL, GONSKA ME, HARTLEY B, et al: In situ expression of tumor necrosis factor-alpha, interferon-gamma, interleukin-2 receptors in renal allograft biopsies. Transplantation 54:1017-1024, 1992
29. NORONHA IL, KRUGER C, ANDRASSY K, et al: In situ production of TNF-α, IL-1β and 1L-2 receptors in ANCA-positive glomerulonephritis. Kidney Int 43:682-692, 1993
30. LUCENA SB, DUARTE MEL, FONSECA EC: Plastic embedded undecalcified bone biopsies: An immunohistochemical method for routine study of bone marrow extracellular matrix. J Histotechnology 20:1-5, 1997
31. HESTEBECH J, HANSEN HE, AMDISEN A, OLSEN S: Chronic renal lesions following long-term treatment with lithium. Kidney Int 12:205-213, 1977
32. JOHNSON WJ, MCCARTHY JT, VAN HEERDEN JA, et al: Results of subtotal parathyroidectomy in hemodialysis patients. Am J Med 84:23-32, 1988
33. DREZNER MK, NEELON FA, JOWSEY J, LEBOVITZ HE: Hypoparathyroidism: A possible cause of osteomalacia. J Clin Endocrinol Metab 45:114-122, 1977
34. SABATINI M, BOYCE B, AUFDEMORTE T, et al: Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci USA 85:5235-5239, 1988
35. LORENZO JA, SOUZA SL, ALANDER C, et al: Comparison of the bone-resorbing activity in the supernatants from phytohemaglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin-1. Endocrinology 121:1164-1170, 1987
36. MAKAROV SS, OLSEN JC, JOHNSTON WN, et al: Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93:402-406, 1996
37. STASHENKO P, DEWHIRST FE, PEROS WJ, et al: Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 138:1464-1468, 1987
38. PEREIRA BJG, SHAPIRO L, KING AJ, et al: Plasma levels of IL-1α, TNF-α and their specific inhibitors in undialysed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994
39. RADEFF JM, NAGY Z, STERN PH: Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Exp Cell Res 268:179-188, 2001
40. DUARTE MEL, CARVALHO EF, CRUZ EAS, et al: Cytokine accumulation in osteitis fibrosa of renal osteodystrophy. Braz J Med Biol Res 35:25-29, 2002
41. DIAMOND JR, VAN GOOR H, DING G, ENGELMYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
42. PFEILSCHIFTER J, LAUKHUF F, MULLER-BECKMANN B, et al: Parathyroid hormone increases the concentration of insulin-like growth factor and transforming growth factor beta in rat bone. J Clin Invest 96:767-774, 1995
43. PICTON ML, MOORE PR, MAWER EB, et al: Down-regulation of human osteoblats PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58:1440-1449, 2000
44. JONGEN JW, WILLEMSTEIN-VAN HOVE EC, VAN DER MEER JM, et al: Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by transforming growth factor-beta in primary fetal rat osteoblasts. Endocrinology 136:3260-3266, 1995
45. PUN S, DEARDEN RL, RATKUS AM, et al: Decreased bone anabolic effect of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats. Bone 28:220-226, 2001
46. BURGER PE, LUKEY PT, COETZEE S, WILSON EL: Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells. J Cell Physiol 190:83-91, 2002
47. CHIKAZU D, KATAGIRI M, OGASAWARA T, et al: Regulation of osteoclast differentiation by fibroblast growth factor 2: Stimulation of receptor activator of nuclear factor kappa B ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J Bone Miner Res 16:2074-2081, 2001
48. NG YY, FAN JM, Mu W, et al: Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 14:2860-2872, 1999